Data / Form D filings / NeuroOne, Inc.
NeuroOne, Inc.: Form D filings
NeuroOne, Inc., a biotechnology company in Eden Prairie, MN, filed 3 Form D notices with the SEC between 2016 and 2017. The latest, on June 15, 2017, reports $1.5 million sold of a $2.5 million offering to 14 investors.
Find out what NeuroOne, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 10006 Liatris Lane, Eden Prairie, MN, 55347
- Phone
- (952) 237-7412
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2016
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1690435
The full lists. Form D filings in Minnesota: 692 rows, $34.60, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 15, 2017 | Amendment | $2,500,000 | $1,525,120 | $974,880 | 14 | Nov 21, 2016 | sec.gov |
| Jan 5, 2017 | Amendment | $1,500,000 | $700,000 | $800,000 | 5 | Nov 21, 2016 | sec.gov |
| Dec 5, 2016 | New notice | $1,500,000 | $300,000 | $1,200,000 | 2 | Nov 21, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Mark A Christianson | Executive Officer | |
| Wade A Fredrickson | Executive Officer | |
| Suraj A Kalia | Director | |
| Jeff A Mathiesen | Director | |
| Paul Buckman | Director | |
| Thomas A Bachinski | Executive Officer | |
| David A Rosa | Executive Officer, Director |
Other biotechnology companies in Minnesota that filed recently
- Medical 21, Inc. $550,000 · Oct 23, 2026
- InSitu Biologics, Inc. $1.3 million · Oct 14, 2026
- Evia Bio, Inc. $5.5 million · Sep 28, 2026
- EyeMacular Regeneration, Inc. $2.9 million · Sep 25, 2026
- ProEncia Biotechnology Inc. $1.5 million · Aug 26, 2026
Every Form D from the week of Jun 12, 2017 · All recent filings in Minnesota · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what NeuroOne, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.